AdvanSource Biomaterials
Chemicals & Related Products · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9115 Harris Corners Pkwy Ste 300, Charlo...Website
www.advbiomaterials.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AdvanSource Biomaterials
AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. The company also manufactures specialty hydrophilic polyurethanes. It sells its products directly to the customers in the United States. The company was formerly known as CardioTech International, Inc. and changed its name to AdvanSource Biomaterials Corporation in October 2008. AdvanSource Biomaterials Corporation was founded in 1993 and is headquartered in Wilmington,...Explore more
AdvanSource Biomaterials Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AdvanSource Biomaterials your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AdvanSource Biomaterials recently announced quarterly report
Product Launch: Get notified when AdvanSource Biomaterials launches new products
AdvanSource Biomaterials, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at AdvanSource Biomaterials
Check out if AdvanSource Biomaterials is spiking on competitors!
Check if AdvanSource Biomaterials has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once AdvanSource Biomaterials has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AdvanSource Biomaterials had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at AdvanSource Biomaterials
Find more new buyers
Compare Similar Companies to AdvanSource Biomaterials
Compare insights from companies similar to AdvanSource Biomaterials, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AdvanSource Biomaterials is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AdvanSource Biomaterials is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AdvanSource Biomaterials.
AdvanSource Biomaterials Tech Stack
A closer look at the technologies used by AdvanSource Biomaterials
AdvanSource Biomaterials News & Media
EKIMAS Corporation Announces Special Cash Distribution
Las Vegas, NV, Sept. 09, 2022 (GLOBE NEWSWIRE) -- EKIMAS Corporation (OTC Pink: “ASNB”) today announced that the Company’s Board of Directors approved a special cash distribution of $0.25 per share at its September 8, 2022 meeting. The cash distribution is payable on September 19, 2022 to shareholders of record as of March 11, 2022.AdvanSource Biomaterials Corporation Announces Completion of the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America
WILMINGTON, Mass, Feb. 03, 2020 (GLOBE NEWSWIRE) -- AdvanSource Biomaterials Corporation (OTC: ASNB) (“AdvanSource” or the “Company”), a materials technology company specializing in medical grade polymers for long and short term applications, announced today that on Friday, January 31, 2020, substantially all of its assets were sold to Mitsubishi Chemical Performance Polymers, Inc. (“Mitsubishi Chemical Performance Polymers” or “MCPP”). As previously announced, AdvanSource entered inMitsubishi Chemical to acquire AdvanSource Biomaterials' TPU business
TOKYO—Mitsubishi Chemical has agreed to purchase the TPU elastomer business of Wilmington, Mass.-based AdvanSource Biomaterials, a move intended to strengthen its position within the medical sector.AdvanSource Biomaterials Corporation Enters Into a Definitive Agreement to Sell Substantially All of Its Assets to a Subsidiary of Mitsubishi Chemical America
WILMINGTON, Mass.--(BUSINESS WIRE)--AdvanSource Biomaterials Corporation (OTC: ASNB) (“AdvanSource” or the “Company”), a materials technology company specializing in medical grade polymers for long and short term applications, announced today that it has entered into a definitive Asset Purchase Agreement with Mitsubishi Chemical Performance Polymers, Inc. (“Mitsubishi Chemical Performance Polymers” or “MCPP”), a subsidiary of Mitsubishi Chemical America, Inc. and its shareholder, Mitsubishi Che
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AdvanSource Biomaterials
Sign Up For FreeTo access detailed company insights
AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. The company also manufac... Read More
